MyWellbrook Health provides personalized behavioral health services for children, women, and families, utilizing scientifically validated neurocognitive assessments and pharmacogenomic testing to inform treatment plans. The startup addresses mental health challenges by offering tailored psychiatric care and therapy options, available in-person or via telehealth, and covered by insurance.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals, especially children and adolescents, face challenges in accessing personalized and effective behavioral health services due to varying needs and potential underlying genetic factors influencing medication response. Traditional mental health treatment often lacks precise diagnostic tools and tailored approaches, leading to suboptimal outcomes.
Solution
MyWellbrook Health Psychiatry delivers customized behavioral healthcare for children, adolescents, and adults, leveraging scientifically-validated neurocognitive assessments and pharmacogenomic testing to inform individualized treatment plans. The platform offers psychiatric care and therapy options, available both in-person and via telehealth, to address a wide range of mental health conditions. By integrating neurocognitive testing, MyWellbrook strengthens diagnostic accuracy and measures progress, while pharmacogenomic testing helps clinicians understand how patients may respond to specific medications. This approach ensures that each patient receives a tailored care plan designed to optimize their mental health outcomes.
Target Audience
The primary target audience includes children, adolescents, and adults seeking personalized behavioral health services, as well as families and individuals with specific needs such as women's mental health, autism assessment, and medication management informed by genetic testing.
Features
- Psychiatric care and medication management for children, adolescents, and adults (ages 5+)
- Specialized women’s mental health services, including perinatal and post-partum care
- Neurocognitive assessments to measure memory, attention, reasoning, and verbal abilities, informing treatments for conditions like autism, ADHD, PTSD, schizophrenia, and depression
- Pharmacogenomic (GeneSight) testing to analyze genetic variations and predict medication response for depression, anxiety, and ADHD
- Cognitive behavioral therapy for adults and adolescents
- Autism diagnostic evaluations (ADOS) for patients ages 5 and up
- Bilingual clinicians and staff, including Spanish and Chinese speakers
- Flexible appointment scheduling with weekday, weekend, and evening availability via telehealth